Furtheremore, our results showed that melatonin-plus-As2O3 decreased the survival rate of breast cancer-derived MCF-7 cells by triggering a caspase-3-dependent apoptosis probably through suppressing the expression of anti-apoptotic target genes of NF-κB. This evidence concerns the gene NFKB1 and breast cancer.